Episodes (Page 5)
✨
Intensity Therapeutics CEO Lewis Bender discusses the importance of trying, even with the risk of failure.
✨
iTeos Therapeutics CEO Michel Detheux is driven by science to help patients.
✨
Triplet Therapeutics CEO Nessan Bermingham advises leaders to be fair and listen.
Nessan Bermingham
✨
Ocular Therapeutix CEO Antony Mattessich believes CEOs should avoid repetitive tasks.
Antony Mattessich
✨
Welcome to Season 2 of BioBoss with host John Simboli.
✨
Compass Pathways CEO George Goldsmith finds creativity in idea transformation.
George Goldsmith
✨
Corbus Pharmaceuticals CEO Yuval Cohen expresses a deep love for biology.
✨
Platelet BioGenesis co-founder Sven Karlsson shifted focus from tasks to problem-solving.
✨
HiFiBiO CEO Liang Schweizer advocates for authentic leadership and vision.
Liang Schweizer
✨
Zageno CEO Florian Wegener emphasizes the power of asking the right questions.
Florian Wegener
✨
Oxford Biomedica CEO John Dawson emphasizes decisive leadership and quick correction.
John Dawson
✨
Rallybio co-founder Martin Mackay stresses the importance of listening to all voices.
Martin Mackay
✨
Torigen Pharma CEO Ashley Kalinauskas prefers the title 'Founder' over 'CEO'.
Ashley Kalinauskas
✨
Kleo Pharmaceuticals CEO Doug Manion compares small pharma to movie making.
Doug Manion
✨
CaroGen Corporation CEO Bijan Almassian identifies courage as essential for leaders.
Bijan Almassian
✨
Bioasis Technologies CEO Mark Day focuses on goals and driving science forward.
✨
Trevi Therapeutics CEO Jennifer Good champions eternal optimism in a tough industry.
✨
ReNetX Bio CEO Erika Smith likens her role to that of an orchestra conductor.
✨
Arvinas CEO John Houston aimed to build something significant.
✨
BioBoss offers direct insights from biopharma leaders and founders.